Jazz Pharmaceuticals and AbCellera Partner for T-cell Antibody Discovery
Jazz Pharmaceuticals and AbCellera announced a collaboration to develop next-generation T-cell engaging multispecific antibodies, aiming to improve outcomes for patients with hematologic malignancies. The partnership, revealed this week, combines AbCellera’s ... Read More